A Keck School study has identified that the protein GRP78, implicated in both cancer and COVID-19, allows cancer to spread and resist treatment. The discovery, published in the Proceedings of the National Academy of Sciences, may enable scientists to protect the involved cells and help prevent further metastasis.

To read the full story, click here.